293 results
Page 4 of 15
8-K
EX-99.1
v8go52 zdmd8p
11 Feb 21
Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing Schedule
10:39am
8-K
EX-99.1
imgp8fi5f sd
26 Jan 21
Other Events
11:19am
8-K
EX-99.1
o31urk4e
15 Jan 21
Other Events
11:34am
8-K
q902sv d8g3pp6e2wf
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
EX-10.1
xown hnrslsp
21 Dec 20
Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
4:18pm
8-K
EX-99.1
fqqh9o8gx86z8xosobw5
7 Dec 20
Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
1:22pm
8-K
EX-99.1
42tj3ojb9z5a
5 Nov 20
Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
4:09pm
8-K
EX-99.1
blimw56
20 Oct 20
Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance
11:59am
8-K
EX-99.1
ixlah
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-99.2
c55os
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-1.1
tmpx5hz50y8iyvl
30 Sep 20
Cardiff Oncology Announces Proposed Public Offering
4:09pm
8-K
EX-99.1
xbupg
17 Sep 20
Other Events
11:18am
8-K
EX-99.1
tjc9jekwoa 6e
15 Sep 20
Cardiff Oncology to Host Key Opinion Leader Call Discussing KRAS-Mutated Colorectal Cancer and Highlighting Data from Onvansertib Phase 1b/2 Trial
10:36am
8-K
EX-99
hb2b1u6kq42
14 Sep 20
Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
11:55am
8-K
EX-99.1
z2fs80 zvrd0aqllo6g
11 Aug 20
Cardiff Oncology Announces Second Quarter 2020 Results and Highlights
4:04pm
8-K
EX-10.1
6gxevf 6o5vrseect
16 Jun 20
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
4:26pm
8-K
EX-99.1
xh6hptqbjgp
16 Jun 20
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
4:26pm
8-K
EX-99.1
81ac qpce1efn8k
15 Jun 20
Other Events
11:50am
8-K
EX-99.1
z97mw1efgp4v51flh
9 Jun 20
Other Events
11:26am